Streetbeat News

BNZI

Banzai International, Inc.

https://www.banzai.io

Industry

Software - Application

Banzai International, Inc., a marketing technology company, provides data-driven marketing and sales solutions for various businesses in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its products include Demio, a browser-based webinar platform with data and marketing features designed to help businesses engage with their audience through live events and on-demand, interactive video content; and Boost, a SaaS solution for social sharing by event registrants. The company serves financial services, e-commerce, technology, and other industries. Banzai International, Inc. was founded in 2015 and is based in Bainbridge Island, Washington.

Open

1.59

Mkt cap

7.4M

Volume

157K

High

1.64

P/E Ratio

-0.30

52-wk high

828.50

Low

1.56

Div yield

N/A

52-wk low

1.56

The SEC has declared the Form S-1 registration statement of Banzai (BNZI) effective, paving the way for its initial public offering (IPO).

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 1:34 pm

Banzai has executed a Letter of Intent (LOI) to acquire Boast. The financial terms of the deal have not been disclosed to the public.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 1:32 pm

Banzai has executed a Letter of Intent (LOI) to acquire Cliently, a company specializing in lead engagement software. The financial terms of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:34 pm

Banzai, a company that provides engagement marketing solutions, has signed a non-binding letter of intent to acquire Cliently, a lead engagement platform. The acquisition aims to integrate Cliently with Banzai's existing products to enhance their offerings.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:33 pm

RxSight, Inc. (RXST) shares surged by 20% after providing FY23 and FY24 revenue guidance above estimates and following a price target increase by Needham. Other stocks experienced significant movement, with Harpoon Therapeutics, Inc. (HARP) and Ambrx Biopharma Inc. (AMAM) seeing major gains due to acquisition announcements. Conversely, LumiraDx Limited (LMDX) and Solo Brands, Inc. (DTC) faced steep declines, with LumiraDx facing Nasdaq suspension and Solo Brands lowering its full year 2023 revenue guidance.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 6:36 pm

LumiraDx Limited (NASDAQ:LMDX) shares plummeted over 30% in pre-market trading due to the announcement that its securities will be suspended from Nasdaq trading starting January 9th. Other stocks experienced significant movement in pre-market trading, with Harpoon Therapeutics, Inc. (NASDAQ:HARP) seeing a near 100% gain after reports of Merck's acquisition talks, and Spirit AeroSystems Holdings, Inc. (NYSE:SPR) dropping over 16% following the FAA's grounding of certain Boeing 737 Max 9 aircraft.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 1:20 pm

U.S. stocks saw gains with the Dow Jones rising by 50 points. Constellation Brands Inc (NYSE:STZ) reported Q3 earnings with higher-than-expected EPS but lower sales, leading to a reduced FY24 EPS outlook. AxoGen, Inc. (NASDAQ:AXGN) shares surged on positive preliminary revenue and CEO retirement news. Banzai International, Inc. (NASDAQ:BNZI) spiked after announcing a letter of intent to acquire IGLeads. Revelstone Capital Acquisition Corp. (NASDAQ:RCAC) saw a jump in shares after cancelling a special meeting for a business combination. Applied Therapeutics, Inc. (NASDAQ:APLT), agilon health, inc. (NYSE:AGL), and Medical Properties Trust, Inc. (NYSE:MPW) experienced significant share price drops due to negative clinical trial results, lowered financial outlook, and exposure reduction plans, respectively. Crude oil prices increased by 2.3%, while gold saw a slight decline.

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 7:30 pm

Applied Therapeutics, Inc. (NASDAQ:APLT) shares plummeted by over 35% after announcing topline results from the ARISE-HF Phase 3 trial of AT-001, which did not meet its primary endpoint. Other stocks experienced significant movement in Friday's mid-day session, with various companies reporting gains due to positive updates, acquisitions, and earnings, while some faced declines due to negative guidance, downgrades, and public offerings.

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 6:13 pm

U.S. stocks were mixed with the Dow Jones falling and NASDAQ rising. The ISM services PMI dropped to 50.6 in December, the lowest in seven months. Consumer discretionary shares led gains, while health care saw minimal increases. Dermata Therapeutics, Banzai International, and Revelstone Capital Acquisition saw significant stock increases due to positive company developments. Conversely, Applied Therapeutics, agilon health, and Medical Properties Trust experienced substantial stock declines following negative company news and analyst downgrades.

Portfolio Pulse from Avi Kapoor

January 05, 2024 | 5:11 pm

Banzai, Inc. shares have seen an uptick following the announcement that the company has signed a Letter of Intent (LOI) to acquire IGLeads. This strategic move could potentially expand Banzai's market reach and product offerings, signaling growth prospects that are positively received by investors.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:46 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.